Program Surveillance After Breast Cancer Treatment: Much Needed, but Still not Ready for Clinical Practice?

Publisher： Karger

E-ISSN： 1661-3805|2|6|356-356

ISSN： 1661-3791

Source： Breast Care, Vol.2, Iss.6, 2008-01, pp. : 356-356

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Program Surveillance after Breast Cancer Treatment: Contra

By  

Breast Care, Vol. 2, Iss. 6, 2008-01 ,pp. : 354-355

Karger

Access to resources Recommend Favorite

Program Surveillance in Women with Early Breast Cancer – Pro

By  

Breast Care, Vol. 2, Iss. 6, 2008-01 ,pp. : 352-353

Karger

Access to resources Recommend Favorite

Palbociclib: First CDK4/6 Inhibitor in Clinical Practice for the Treatment of Advanced HR-Positive Breast Cancer

By  

Breast Care, Vol. 11, Iss. 3, 2016-06 ,pp. : 174-176

Karger

Access to resources Recommend Favorite

Biosimilars in the Treatment of Breast Cancer

By  

Breast Care, Vol. 12, Iss. 3, 2017-06 ,pp. : 192-194

Karger

Access to resources Recommend Favorite

Disease Management Program Breast Cancer – First Experience

By  

Breast Care, Vol. 1, Iss. 3, 2006-07 ,pp. : 152-156

Karger

Access to resources Recommend Favorite